Make a Donation

Be a part of the change

WELCOME TO DDRFA

WE ARE FIFTY + SEPARATE NON PROFITS & FUNDS

which make grants together for research, trial access and data integration or utilization. We are passionate about providing funds to develop an understanding of Diffuse Midline Gliomas, including Diffuse Intrinsic Pontine Gliomas.  In our five months, we have funded $1.1 Million together for DIPG DMG research, data, trials and the national tumor board formation.  We’re not done.  Our next competitive grant round will be awarded in April 2023.  We continue to fund projects that matter to families fighting DIPG DMG.

Our Goal is to Fund Research

access to treatment, prevention, diagnostics and better use of data in DIPG/DMG. One day soon we hope to help our committed researchers and doctors by together funding the cure for this most deadly childhood brain tumor.

ABOUT DIPG | DMG

Diffuse Midline Gliomas, including Diffuse Intrinsic Pontine Gliomas, are cancerous brain tumors considered terminal at diagnosis.  Generally, at diagnosis, a patient is given less than one year to live.  DIPG most typically affects children ages 4 to 12.  However, DIPG and DMG can impact children or adults. DIPG/DMG takes the walk, talk, speech, swallow, use of hands and arms, eyesight, and hearing of the person impacted. Usually one side of the body and the opposite side of the head is affected. Symptoms often start with double vision or an eye turning inward, maybe a slight limp or unsteadiness.  Over time the symptoms will progress until this cancerous tumor takes the last breath and stops the heart of the person with DIPG/DMG.  Standard treatment has not changed for over 60 years. However, working together with committed researchers and providers, we believe a better future for those with DIPG/DMG is within reach.

ABOUT DDRFA

The DIPG DMG Research Funding Alliance was established 2-22-2022 by nonprofits desiring to fund research, trial access, and data needs at the speed of DIPG/DMG.  We are powered by families and we won’t stop working to end DIPG/DMG as we know it.  Each member knows all too well that lives depend on us. Our Medical Advisory Council guides our funding by reviewing grants and engaging regularly with our grantees to champion collaborative efforts necessary to change the course of DIPG/DMG.

Announcing DDRFA’s First Investment:
The first step in changing the course of  DIPG / DMG.

Adam Green, MD

Pediatric Neuro Oncology
Children’s
Hospital of Colorado

Ashley Plant-Fox, MD

Pediatric Neuro Oncology
Lurie Children’s Hospital

Carl Koschmann, MD

Pediatric Neuro Oncology
CS Mott Children’s Hospital

Cheng-Chia Wu, MD, PhD

Radiation Oncologist
COLUMBIA UNIVERSITY IRVING MEDICAL CENTER

David Mirsky, MD

PEDIATRIC NEURORADIOLOGIST
CHILDREN’S HOSPITAL COLORADO

Jason Fangusaro, MD

Pediatric Neuro Oncology
Children’s Healthcare of Atlanta

Matthew Barkovich, MD

Neuroradiologist 
UCSF Benioff Children’s Hospital

Michelle Monje, MD, PHD

Pediatric Neuro Oncology
Lucile Packard Children’s Hospital

Nicholas Vitanza, MD

Pediatric Neuro Oncology
Seattle Children’s Hospital

Patricia Baxter, MD, MBA

Pediatric Neuro Oncology
Texas Children’s Hospital

Sabine Mueller, MD, PhD

Chairperson
Pediatric Neuro Oncology
UCFF benioff Children’s Hospital

Sebastian Waszak, PhD

PROFESSOR OF NEUROLOGY
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (UCSF) 

The DIPG DMG National  Brain Tumor Board is funded by:
The Members of:

Elliot Rose Fund and All In to Win Foundation

Look forward to further Tumor Board Announcements here!